Media Placement at Examiner.com for Identa's Touch and Know Drug Detection Kits
22 June 2013 - 1:30AM
Marketwired
IDenta Corp. (OTC Pink: IDTA) CEO
Yaacov Shoham released today the last Media Placement
at Examiner.com:
http://www.examiner.com/article/use-the-identa-touch-know-drug-test-to-test-your-partner-relationship
Examiner.com (with 10.387.374 unique monthly visitors) featured
a review of the Identa - Touch and Know kit.
Examiner.com provides hyper localized content and serves as a
daily news and entertainment hub comprised of several regional
editions.
Marketed under the brand name Touch&Know™, the
over-the-counter unit combines safety, accuracy, affordability and
ease of use for the consumer. The kit, based on proven field tests
used extensively by law enforcement worldwide, is based on
technology which is now available to the general public for the
first time ever.
"Touch&Know™ is the first non-biological drug testing kit offered by a US
retailer," explained Shoham. "Touch&Know™ safely tests the
substance, as opposed to the person, and provides immediate
results. It is a fully non-invasive method. We are proud to have
partnered with the drug store chain, the largest retail pharmacy
chain in America, to make this product available to all consumers."
The drug store chain operates more than 8600 outlets in all 50 US
states.
Touch&Know™ contains two detectors: one for general
screening and one for marijuana/hashish. The patented retail
package is able to detect 22 different kinds of illegal drugs.
The testing kit provides immediate display of results without
lab involvement, ensuring a 99% accuracy rate in results --
environmentally friendly and in a non-confrontational approach
requiring no bodily fluids.
IDenta Corp. is committed to the belief that any effective
anti-drug policy begins with the ability to quickly gather credible
evidence. Touch&Know™ offers the means to do so. The detector
can assist with the resolution of drug-related issues in the home,
schools and businesses.
For interviews and additional information,
please contact:
Ephraim Ruttner President
Oximeter Plus, Inc.
eruttner@oximeterplus.com www.oximeterplus.com 516 626-6226 Ext
300
Operating since 2003, IDenta Corporation
(www.touchandknow.net, www.identa-corp.com) has been recognized as
a worldwide leader in the development of proprietary on-site drug,
drug precursor and explosive detection kits. IDenta develops,
manufactures and distributes products for both the professional and
consumer markets which consistently pass the highest qualifications
and testing procedures of law enforcement and security agencies
worldwide. Additional information may be accessed at
www.drugsdetector.com, and www.identa.biz.
Disclaimer:
Certain statements contained herein may be, within the meaning
of the Federal securities laws, "forward-looking statements" that
are subject to risks and uncertainties that could cause actual
results to differ materially from those described in the
forward-looking statements. Such forward-looking statements involve
known and unknown risks, uncertainties and other factors which may
cause the actual results, performance or achievements of the
company to be materially different from any future results,
performance or achievements expressed or implied by such
forward-looking statements. These forward-looking statements are
based on management's expectations as of the date hereof, and the
company does not undertake any responsibility to update any of
these statements in the future.
For Investor Relations, lobbying interests or information
concerning IDenta's products internationally or the development of
new chemical detectors,
Contact: Yaacov Shoham CEO IDenta Corp. Mobile: +972-52-6554487
fpi@drugsdetector.com Site: www.drugsdetector.com
www.identa-corp.com www.touchandknowusa.com
Identa (QB) (USOTC:IDTA)
Historical Stock Chart
From Oct 2024 to Nov 2024
Identa (QB) (USOTC:IDTA)
Historical Stock Chart
From Nov 2023 to Nov 2024
